Literature DB >> 29545871

Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1.

Hongxia Yang1, Gang Zhang2, Xiaolin Che3, Shudong Yu4.   

Abstract

Slug is associated with the radioresistance of nasopharyngeal carcinoma (NPC) and the main current approach of treatment for NPC is radiotherapy. Hence, the aim of the current study was to determine the effect of Slug silencing on the radiosensitivity of NPC cells. Lentiviral-mediated transfection of Slug RNA interference (RNAi) in NPC cell line C666-1 was performed in vitro. Following Slug inhibition, its expression was detected using western blotting. A clonogenic survival assay and flow cytometry were then performed to evaluate the clonogenic cell survival, cell cycle distribution and apoptosis of C666-1 cells following irradiation. The results indicated that Slug RNAi decreased cell proliferation, and increased cell apoptosis and G0/G1 arrest. Thus, lentiviral-mediated transfection of Slug RNAi enhanced the radiosensitivity of the NPC cell line C666-1, and Slug may therefore be a potential target to improve radiotherapy in treatment of NPC and reduce the radioresistance of NPC.

Entities:  

Keywords:  NPC; lentivirus; radiosensitivity; slug

Year:  2018        PMID: 29545871      PMCID: PMC5840900          DOI: 10.3892/etm.2018.5844

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  35 in total

1.  Cancer incidence in five continents. Volume VIII.

Authors: 
Journal:  IARC Sci Publ       Date:  2002

2.  Current treatment of nasopharyngeal carcinoma.

Authors:  Anthony T C Chan
Journal:  Eur J Cancer       Date:  2011-09       Impact factor: 9.162

Review 3.  Nasopharyngeal carcinoma: the next challenges.

Authors:  Albiruni R A Razak; Lillian L Siu; Fei-Fei Liu; Emma Ito; Brian O'Sullivan; Kelvin Chan
Journal:  Eur J Cancer       Date:  2010-05-05       Impact factor: 9.162

4.  Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma.

Authors:  John Waldron; Mo Mo Tin; Anne Keller; Cheemun Lum; Barbara Japp; Susanna Sellmann; Monique van Prooijen; Leah Gitterman; Ralph Blend; David Payne; Fei-Fei Liu; Padraig Warde; Bernard Cummings; Melania Pintilie; Brian O'Sullivan
Journal:  Radiother Oncol       Date:  2003-08       Impact factor: 6.280

5.  Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.

Authors:  Paul Finnon; Sylwia Kabacik; Alan MacKay; Claudine Raffy; Roger A'Hern; Roger Owen; Christophe Badie; John Yarnold; Simon Bouffler
Journal:  Radiother Oncol       Date:  2012-11-15       Impact factor: 6.280

6.  Utilization of the ferrous sulfate (Fricke) dosimeter for evaluating the radioprotective potential of cystamine: experiment and Monte Carlo simulation.

Authors:  Ridthee Meesat; Sunuchakan Sanguanmith; Jintana Meesungnoen; Martin Lepage; Abdelouahed Khalil; Jean-Paul Jay-Gerin
Journal:  Radiat Res       Date:  2012-04-04       Impact factor: 2.841

7.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

Review 8.  The EMT regulator slug and lung carcinogenesis.

Authors:  Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

9.  Slug, a zinc finger gene previously implicated in the early patterning of the mesoderm and the neural crest, is also involved in chick limb development.

Authors:  M A Ros; M Sefton; M A Nieto
Journal:  Development       Date:  1997-05       Impact factor: 6.868

10.  SLUG silencing increases radiosensitivity of melanoma cells in vitro.

Authors:  Chiara Arienti; Anna Tesei; Silvia Carloni; Paola Ulivi; Antonino Romeo; Giulia Ghigi; Enrico Menghi; Anna Sarnelli; Elisabetta Parisi; Rosella Silvestrini; Wainer Zoli
Journal:  Cell Oncol (Dordr)       Date:  2012-12-19       Impact factor: 6.730

View more
  4 in total

1.  The effects of growth hormone on therapy resistance in cancer.

Authors:  Reetobrata Basu; John J Kopchick
Journal:  Cancer Drug Resist       Date:  2019-09-19

2.  Trichostatin A reverses epithelial-mesenchymal transition and attenuates invasion and migration in MCF-7 breast cancer cells.

Authors:  Xiaoxiong Wang; Shirong Chen; Taipeng Shen; Hao Lu; Dingqiong Xiao; Meng Zhao; Yutang Yao; Xiuli Li; Ge Zhang; Xing Zhou; Xiao Jiang; Zhuzhong Cheng
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

3.  CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer.

Authors:  Jeong-Yub Kim; Hee-Jin Kim; Chan-Woong Jung; Tae Sup Lee; Eun Ho Kim; Myung-Jin Park
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

4.  Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma.

Authors:  Zhen Wu; Xiaoling Zhang; Pinjing Liu; Aiyou Wei; Wei Ouyang; Shengjun Xiao
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.